Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


04.12.2017

1 AJR Am J Roentgenol
1 Am J Gastroenterol
4 Anticancer Res
1 BMC Surg
2 Br J Surg
1 Gut
1 J Cancer Res Clin Oncol
1 J Surg Oncol
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LIANG P, Ren XC, Gao JB, Chen KS, et al
    Iodine Concentration in Spectral CT: Assessment of Prognostic Determinants in Patients With Gastric Adenocarcinoma.
    AJR Am J Roentgenol. 2017 Sep 5:1-6. doi: 10.2214/AJR.16.16895.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. CROCETTI E, Mancini S, Ravaioli A, Giuliani O, et al
    The Relationship Between Gastric and Esophageal Cancers in Italy.
    Am J Gastroenterol. 2016;111:1201-2.
    PubMed     Text format    


    Anticancer Res

  3. NISHI M, Batsaikhan BE, Yoshikawa K, Higashijima J, et al
    High STAT4 Expression Indicates Better Disease-free Survival in Patients with Gastric Cancer.
    Anticancer Res. 2017;37:6723-6729.
    PubMed     Text format     Abstract available

  4. MASUISHI T, Kadowaki S, Kondo M, Komori A, et al
    FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis.
    Anticancer Res. 2017;37:7037-7042.
    PubMed     Text format     Abstract available

  5. FUJII H, Iihara H, Kajikawa N, Kobayashi R, et al
    Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy.
    Anticancer Res. 2017;37:6831-6837.
    PubMed     Text format     Abstract available

  6. INOKUCHI M, Higuchi K, Takagi Y, Tanioka T, et al
    Cadherin 5 Is a Significant Risk Factor for Hematogenous Recurrence and a Prognostic Factor in Locally Advanced Gastric Cancer.
    Anticancer Res. 2017;37:6807-6813.
    PubMed     Text format     Abstract available


    BMC Surg

  7. BAUSYS R, Bausys A, Vysniauskaite I, Maneikis K, et al
    Risk factors for lymph node metastasis in early gastric cancer patients: Report from Eastern Europe country- Lithuania.
    BMC Surg. 2017;17:108.
    PubMed     Text format     Abstract available


    Br J Surg

  8. NOBLE F, Lloyd MA, Turkington R, Griffiths E, et al
    Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
    Br J Surg. 2017;104:1816-1828.
    PubMed     Text format     Abstract available

  9. KAWAKATSU S, Ohashi M, Hiki N, Nunobe S, et al
    Use of endoscopy to determine the resection margin during laparoscopic gastrectomy for cancer.
    Br J Surg. 2017;104:1829-1836.
    PubMed     Text format     Abstract available


    Gut

  10. GUETA I, Halkin H, Markovits N, Loebstein R, et al
    Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12.
    Gut. 2017 Nov 28. pii: gutjnl-2017-315695. doi: 10.1136/gutjnl-2017-315695.
    PubMed     Text format    


    J Cancer Res Clin Oncol

  11. LI S, Lan X, Gao H, Li Z, et al
    Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.
    J Cancer Res Clin Oncol. 2017;143:2455-2468.
    PubMed     Text format     Abstract available


    J Surg Oncol

  12. LIU X, Li G, Long Z, Yin J, et al
    Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer.
    J Surg Oncol. 2017 Nov 30. doi: 10.1002/jso.24917.
    PubMed     Text format     Abstract available


    World J Surg

  13. LEE D, Lee JH, Choi D, Kang CM, et al
    Surgical Strategy and Outcome in Patients Undergoing Pancreaticoduodenectomy After Gastric Resection: A Three-Center Experience with 39 Patients.
    World J Surg. 2017;41:552-558.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: